维普中文期刊产品整合服务
58篇 您的检索式:作者名="FILE TM JR"
    题名 作者 年代 出处 被引量
1Burden of community-acquired pneumonia in North American adults 显示文摘File TM Jr Marrie TJ 2010Postgrad Med2010,122,:1
2Respiratory infections unique to Asia 显示文摘Tsang KW File TM Jr 2008Respirology2008,13,7:1
3FOCUS 2: a randomized,dou- ble - blinded, multicentre, Phase IIl trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community- acquired pneumo- nia 显示文摘Low DE File TM Jr Eckburg PB 2011J Ant imicrob Chemother2011,66,3:1
4Guidelines for empiric antimlerobial prescribing in community acquired pneumonia显示文摘File TM Jr Garau J Blasi F 2004Chest2004,125,5:1
5Clinical implications of 750 rag, 5 day levofloxacin for the treatment of community-acquired pneumonia显示文摘File TM Jr Milkovich G Tennenberg AM 2004Curr Med Res Opin2004,20,9:1
6Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacte- remia显示文摘Selickman J Paxos M File TM Jr 2010Diagn Micr Infec Dis2010,67,2:1
7A multi-center, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil intreatment of adults with community-acquired penumonia显示文摘File TM Jr Segreti J Dunbar L 1997Antimicrob Agents Chemother1997,41,9:1
8Incidence of community acquired pneumonia requiring hospitalization 显示文摘Marston B J Plouffe JF File TM Jr 1997Arch Intern Med1997,157,15:1
9Safety of intravenous infusion of doripenem显示文摘REDMAN R FILE TM Jr 2009Clin Infect Dis2009,49,1:1
10Management of community- acq-uired pneumonia: a focus on conversion from hospital to the ambulatory setting显示文摘Tan JS File TM Jr 2003Am J Respir Med2003,2,5:1
11Clinical implications of 750 mg, 5 day levofloxaein for the treatment of community-acquired pneumonia显示文摘File TM Jr Milkovich G Tennenberg AM 2004Curr Med Res Opin2004,20,9:1
12Summary of ceftaroline fosamil clinical trial studies and clinical safety显示文摘File TM Wilcox Jr MH Stein GE 2012Clin Infect Dis2012,55,3:1
13Double-blind, randomized study of the efficacy and safety of oral pharmacokinetieally enhanced amoxieillin-elavnlanate (2,000/125 milligrams) versus those of amoxieillin-clavulanate (875/ 125 milligrams), both given twice daily tot 7 days, in treatment of bacterial community-acquired pneumonia in adults显示文摘File TM Jr Lode H Kurz H 2004Antimierob Agents Chemother2004,48,9:1
14Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections 显示文摘McConnell CT Jr Plouffe JF File TM 1994Radiology1994,192,3:1
15Clinical implications of 750 mg,5-day levofloxacin for the treatment of community-acquired pneumonia显示文摘File TM Jr Milkovich G Tennenberg AM 2004Curt Med Res Opin2004,20,9:1
16A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or ceftriaxone axetil in treat ment of adults with community-acquired pneumonia显示文摘File TM Jr Segreti Dunbar L 1997Antimicrob Agents Chemother1997,41,5:1
17A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-aquired pneumonia 显示文摘 Segreti J Dunbar L 1997Antimicrob Agents Chemother1997,41,:1
18Respiratory infections unique to Asia 显示文摘TSANG KW FILE TM JR 2008Respirology2008,13,7:1
19Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia 显示文摘File TM Jr Garau J Blasi F 2004Chest2004,125,5:1
20Clinical implications of 750 mg,5-day levofloxacin for the treatment of community-acquired pneumonia显示文摘File TM Jr 2004Curr Med Res Opin2004,20,9:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费